サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1646767

エピジェネティクスの世界市場

Epigenetics

出版日
ページ情報
英文 427 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
エピジェネティクスの世界市場
出版日: 2025年01月31日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 427 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

エピジェネティクスの世界市場は2030年までに55億米ドルに到達

2023年に17億米ドルと推定されるエピジェネティクスの世界市場は、2030年には55億米ドルに達し、分析期間2023-2030年のCAGRは17.9%で成長すると予測されます。本レポートで分析したセグメントの1つであるエピジェネティクスキットは、CAGR 18.9％を記録し、分析期間終了時には22億米ドルに達すると予測されています。エピジェネティクス試薬セグメントの成長率は、分析期間のCAGRで18.0％と推定されます。

米国市場は6億4,110万米ドルと推定、中国はCAGR19.4％で成長予測

米国のエピジェネティクス市場は、2023年に6億4,110万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5億4,970万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは19.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.2%と17.7%と予測されています。欧州では、ドイツがCAGR約17.2%で成長すると予測されています。

世界のエピジェネティクス市場- 主要動向と促進要因まとめ

エピジェネティクスとは何か、なぜ現代医療に変革をもたらすのか？

エピジェネティクスとは、DNA配列の変化を伴わない遺伝子発現の変化を研究するものです。これらの変化は、環境因子、ライフスタイル、細胞内シグナルの影響を受け、DNAメチル化、ヒストン修飾、ノンコーディングRNA相互作用などのメカニズムによって媒介されます。エピジェネティクスは、開発、老化、疾病の進行などの生物学的プロセスの制御において重要な役割を担っており、現代医学における革新的な研究・応用分野となっています。

エピジェネティクスの変革の可能性は、環境因子やライフスタイルの選択が遺伝子発現や健康結果にどのような影響を与えるかについての洞察を提供する能力にあります。エピジェネティックな修飾は、遺伝子変異とは異なり可逆的であるため、治療介入の魅力的なターゲットとなります。例えば、ヒストン脱アセチル化酵素（HDAC）阻害剤やDNAメチル化酵素阻害剤などのエピジェネティック療法は、がん、神経変性疾患、代謝性疾患の治療のために開発されています。エピジェネティックなメカニズムを理解し、それを標的とすることで、研究者は疾患の根本原因に対処する個別化治療を開発し、精密医療への道を開くことができます。

さらに、エピジェネティクスは診断学や医薬品開発にも大きな影響を与えます。エピジェネティックバイオマーカーは、病気の状態を特定し、病気の進行を予測し、治療効果をモニターするためにますます使用されるようになってきています。特異的なメチル化パターンなどのこれらのバイオマーカーは、がんなどの疾患の早期発見や非侵襲的診断法を可能にします。医薬品開発においては、エピジェネティックスクリーニングにより、研究者は新規の創薬標的を同定し、治療戦略を最適化することができ、技術革新を加速し、患者の転帰を改善することができます。遺伝学と環境の架け橋として、エピジェネティクスは健康と病気についての理解を深め、医療の未来に革命をもたらす中心的存在です。

技術の進歩と業界の要求は、エピジェネティクス市場をどのように形成していますか？

シーケンス、イメージング、計算ツールの技術的進歩は、より正確でハイスループットかつスケーラブルな調査を可能にし、エピジェネティクス市場を牽引しています。全ゲノムバイサルファイトシークエンシングやChIP-シーケンシングなどの次世代シーケンシング（NGS）技術は、研究者がゲノム全体のDNAメチル化やヒストン修飾をマッピングできるようにすることで、エピジェネティクスの研究に革命をもたらしました。これらのツールは前例のない解像度と精度を提供し、エピジェネティックな変化が遺伝子制御や疾患プロセスにどのように影響するかをより深く理解することを可能にしています。シングルセルシーケンスの進歩により、研究者はエピジェネティック修飾を単一細胞レベルで解析できるようになり、組織や腫瘍における細胞の不均一性を明らかにすることで、これらの能力をさらに高めることができます。

超解像顕微鏡や高度な蛍光イメージングなどの高解像度イメージング技術もまた、クロマチンダイナミクスやヒストン修飾をリアルタイムで可視化することにより、研究に変革をもたらしつつあります。これらのツールにより、科学者はエピジェネティックなマークの空間的な構成と、それらが生きた細胞内で遺伝子発現に与える影響を研究することができ、エピジェネティックな制御の動的な性質についての洞察を得ることができます。計算アルゴリズムやAIを駆使した解析と組み合わせることで、画像データやシーケンスデータを統合して包括的なエピジェネティック・マップを作成し、遺伝子の挙動や疾患の転帰をより正確に予測することができます。

個別化医療に対する需要の高まりは、産業界が標的療法や診断法を開発するための革新的な方法を模索する中で、エピジェネティクス市場をさらに形成しています。エピジェネティクスは、遺伝子発現の個人差や疾患感受性を理解するためのフレームワークを提供し、オーダーメイドの介入法の開発を可能にします。例えば、プレシジョン・オンコロジーはエピジェネティック・バイオマーカーを活用し、腫瘍に特異的な変化を同定し、治療決定を導きます。同様に、エピジェネティックなデータは、個別化されたライフスタイルや栄養勧告の設計に役立ち、予防ヘルスケアをサポートします。シークエンシング、画像診断、個別化医療の進歩が、現代の生物医学研究と治療イノベーションの礎石として、エピジェネティクス市場の成長を牽引しています。

エピジェネティクスは、業界セグメントのどこで最も大きなインパクトを与えているのでしょうか？

エピジェネティクスは、腫瘍学、神経科学、再生医療、農業など、様々な産業セグメントに大きな影響を与えており、それぞれが理解、診断、治療アプローチの強化から恩恵を受けています。腫瘍学において、エピジェネティクスは腫瘍の成長、転移、治療抵抗性の根底にあるエピジェネティックなメカニズムを明らかにすることにより、がんの研究と治療に革命をもたらしています。HDAC阻害剤やDNAメチル化酵素阻害剤などのエピジェネティック療法は、腫瘍抑制遺伝子を再活性化し、がん細胞を化学療法に感作するために使用されています。さらに、エピジェネティック・バイオマーカーは、がんの早期発見と個別化治療戦略を可能にし、患者の転帰を改善し、病気の負担を軽減します。

神経科学では、エピジェネティクスがアルツハイマー病、自閉症、うつ病などの神経発達障害や神経変性障害の分子メカニズムに重要な洞察を与えています。ヒストンアセチル化やDNAメチル化などのエピジェネティック修飾は、脳の可塑性や記憶形成において中心的な役割を果たしています。これらの修飾を標的とすることで、研究者は神経疾患の治療や認知機能回復のための新規治療法を開発しています。また、エピジェネティクスは、メンタルヘルスにおける遺伝学的要因と環境要因の相互作用に光を当て、予防と治療に対する全人的アプローチの開発を可能にしています。

再生医療では、エピジェネティクスが幹細胞研究と組織工学の進歩を牽引しています。多能性の誘導などのエピジェネティックな初期化技術により、科学者は再生治療に使用する患者特異的幹細胞を作り出すことができます。これらの幹細胞は、エピジェネティックな状態を調節することで様々な細胞型に分化させることができ、糖尿病、心血管疾患、脊髄損傷などの疾患に対する個別化治療の開発が可能になります。エピジェネティクスはまた、組織再生の効率を高め、人工組織の安定性を向上させる役割も担っており、再生医療の将来にとって不可欠なものとなっています。

農業分野では、エピジェネティクスは、植物が干ばつ、暑さ、病原菌などの環境ストレス要因にどのように反応するかを理解することにより、作物の回復力、収量、品質を向上させるために利用されています。植物におけるエピジェネティックな修飾は、変化する条件に応答して遺伝子発現を制御するため、科学者は遺伝子組換えなしにストレス耐性の作物品種を開発することができます。このようなエピジェネティックなアプローチは、化学物質への依存を減らし、気候変動に直面する食料安全保障を強化することで、持続可能な農業に貢献します。これらのセグメントにおいて、エピジェネティクスはイノベーション、精密さ、持続可能性をサポートし、その幅広い応用と変革の可能性を強調しています。

エピジェネティクス市場の成長を促進する主な要因は？

エピジェネティクス市場の成長は、慢性疾患や複雑な疾患の有病率の上昇、個別化医療に対する需要の増加、調査技術の進歩など、いくつかの重要な要因によってもたらされます。がん、心血管疾患、神経変性疾患などの慢性疾患の有病率の増加は、これらの疾患がエピジェネティックな修飾に影響されることが多いため、主要な促進要因となっています。エピジェネティクスは疾患メカニズムに対する洞察を提供し、治療選択肢が限られている疾患に対する治療標的を提供し、エピジェネティック研究と医薬品開発への投資を促進します。

個別化医療に対する需要の高まりは、ヘルスケアが病気のかかりやすさや治療に対する反応の個人差に対処する個別化アプローチへとシフトする中で、もう一つの重要な推進力となっています。エピジェネティックバイオマーカーは、患者集団の層別化を可能にし、特に腫瘍学や希少遺伝性疾患における標的療法の開発を導きます。エピジェネティックなデータを用いて治療効果を予測し、疾患の進行をモニターする能力は、医療介入の精度と有効性を高め、プレシジョン・ヘルスケアの広範な動向と一致します。

次世代シーケンシング、シングルセル解析、バイオインフォマティクスを含む調査技術の進歩も市場を後押ししています。これらの技術は、エピジェネティック制御の複雑で動的な性質を探求するために必要なツールを提供し、理解と応用におけるブレークスルーを可能にします。AIと機械学習の統合は、大規模なエピジェネティックデータセットのパターンや相関関係を特定することで発見をさらに加速します。これらの技術的進歩は、調査のコストと複雑さを低減し、学術的、臨床的、商業的事業体にとってより利用しやすいものとなっています。

疾患の流行、個別化医療の需要、技術の進歩といったこれらの促進要因が相まって、エピジェネティクス市場の成長を後押ししています。各業界がエピジェネティックな知見を活用してアンメットメディカルニーズに対応し、分野を超えたイノベーションを続けている中、エピジェネティクスはヘルスケア、農業、そしてその先の未来を形作る上で中心的な役割を果たす準備が整っています。

セグメント

製品（エピジェネティクスキット,エピジェネティクス試薬,エピジェネティクス酵素,エピジェネティクス機器・消耗品）;技術（DNAメチル化技術,ヒストンメチル化技術,ヒストンアセチル化技術, Large Non-Coding RNA技術, MicroRNA修飾技術,クロマチン構造技術）;アプリケーション（腫瘍学アプリケーション,非腫瘍学アプリケーション）

調査対象企業の例（注目の合計95社）

  • Abnova Corporation
  • Active Motif, Inc.
  • biomodal Ltd.
  • Bio-Rad Laboratories, Inc.
  • BPS Bioscience, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • EpiCypher, Inc.
  • Epigentek Group Inc.
  • Fios Genomics Ltd.
  • Genomescan
  • Illumina, Inc.
  • Merck Millipore
  • New England Biolabs, Inc.
  • Novogene Co. Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • Qiagen, Inc.
  • Revvity, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP-6259

Global Epigenetics Market to Reach US$5.5 Billion by 2030

The global market for Epigenetics estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Epigenetics Reagents segment is estimated at 18.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$641.1 Million While China is Forecast to Grow at 19.4% CAGR

The Epigenetics market in the U.S. is estimated at US$641.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$549.7 Million by the year 2030 trailing a CAGR of 19.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 17.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.2% CAGR.

Global Epigenetics Market - Key Trends & Drivers Summarized

What Is Epigenetics and Why Is It Transformative for Modern Medicine?

Epigenetics is the study of changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes are influenced by environmental factors, lifestyle, and cellular signals and are mediated by mechanisms such as DNA methylation, histone modification, and non-coding RNA interactions. Epigenetics plays a crucial role in regulating biological processes, including development, aging, and disease progression, making it a transformative area of research and application in modern medicine.

The transformative potential of epigenetics lies in its ability to offer insights into how environmental factors and lifestyle choices affect gene expression and health outcomes. Epigenetic modifications are reversible, unlike genetic mutations, making them an attractive target for therapeutic intervention. For example, epigenetic therapies, such as histone deacetylase (HDAC) inhibitors and DNA methyltransferase inhibitors, are being developed to treat cancers, neurodegenerative disorders, and metabolic diseases. By understanding and targeting epigenetic mechanisms, researchers can develop personalized therapies that address the root causes of diseases, paving the way for precision medicine.

Additionally, epigenetics has a profound impact on diagnostics and drug development. Epigenetic biomarkers are increasingly being used to identify disease states, predict disease progression, and monitor treatment efficacy. These biomarkers, such as specific methylation patterns, enable early detection and non-invasive diagnostic methods for conditions like cancer. In drug development, epigenetic screening allows researchers to identify novel drug targets and optimize therapeutic strategies, accelerating innovation and improving patient outcomes. As a bridge between genetics and environment, epigenetics is central to advancing our understanding of health and disease and revolutionizing the future of medicine.

How Are Technological Advancements and Industry Demands Shaping the Epigenetics Market?

Technological advancements in sequencing, imaging, and computational tools are driving the epigenetics market by enabling more precise, high-throughput, and scalable research. Next-generation sequencing (NGS) technologies, such as whole-genome bisulfite sequencing and ChIP-sequencing, have revolutionized the study of epigenetics by allowing researchers to map DNA methylation and histone modifications across the genome. These tools provide unprecedented resolution and accuracy, enabling a deeper understanding of how epigenetic changes influence gene regulation and disease processes. Advances in single-cell sequencing further enhance these capabilities by allowing researchers to analyze epigenetic modifications at the single-cell level, uncovering cellular heterogeneity in tissues and tumors.

High-resolution imaging techniques, such as super-resolution microscopy and advanced fluorescence imaging, are also transforming epigenetics research by visualizing chromatin dynamics and histone modifications in real time. These tools allow scientists to study the spatial organization of epigenetic marks and their impact on gene expression within living cells, providing insights into the dynamic nature of epigenetic regulation. Combined with computational algorithms and AI-powered analytics, imaging and sequencing data can be integrated to generate comprehensive epigenetic maps, facilitating more accurate predictions of gene behavior and disease outcomes.

The increasing demand for personalized medicine is further shaping the epigenetics market as industries seek innovative ways to develop targeted therapies and diagnostics. Epigenetics provides a framework for understanding individual variations in gene expression and disease susceptibility, enabling the development of tailored interventions. For example, precision oncology leverages epigenetic biomarkers to identify tumor-specific modifications and guide treatment decisions. Similarly, epigenetic data informs the design of personalized lifestyle and nutritional recommendations, supporting preventive healthcare. Together, advancements in sequencing, imaging, and personalized medicine are driving the growth of the epigenetics market, making it a cornerstone of modern biomedical research and therapeutic innovation.

Where Is Epigenetics Making the Greatest Impact Across Industry Segments?

Epigenetics is making a significant impact across various industry segments, including oncology, neuroscience, regenerative medicine, and agriculture, each benefiting from enhanced understanding, diagnostics, and therapeutic approaches. In oncology, epigenetics is revolutionizing cancer research and treatment by uncovering the epigenetic mechanisms underlying tumor growth, metastasis, and resistance to therapy. Epigenetic therapies, such as HDAC inhibitors and DNA methyltransferase inhibitors, are being used to reactivate tumor suppressor genes and sensitize cancer cells to chemotherapy. Additionally, epigenetic biomarkers enable early cancer detection and personalized treatment strategies, improving patient outcomes and reducing the burden of disease.

In neuroscience, epigenetics is providing critical insights into the molecular mechanisms of neurodevelopmental and neurodegenerative disorders, such as Alzheimer’s disease, autism, and depression. Epigenetic modifications, including histone acetylation and DNA methylation, play a central role in brain plasticity and memory formation. By targeting these modifications, researchers are developing novel therapies to treat neurological conditions and restore cognitive function. Epigenetics also sheds light on the interplay between genetics and environmental factors in mental health, enabling the development of holistic approaches to prevention and treatment.

In regenerative medicine, epigenetics is driving advances in stem cell research and tissue engineering. Epigenetic reprogramming techniques, such as the induction of pluripotency, allow scientists to generate patient-specific stem cells for use in regenerative therapies. These stem cells can be differentiated into various cell types by modulating their epigenetic states, enabling the development of personalized treatments for conditions like diabetes, cardiovascular disease, and spinal cord injuries. Epigenetics also plays a role in enhancing the efficiency of tissue regeneration and improving the stability of engineered tissues, making it integral to the future of regenerative medicine.

In agriculture, epigenetics is being used to improve crop resilience, yield, and quality by understanding how plants respond to environmental stressors, such as drought, heat, and pathogens. Epigenetic modifications in plants regulate gene expression in response to changing conditions, enabling scientists to develop stress-tolerant crop varieties without genetic modification. These epigenetic approaches contribute to sustainable agriculture by reducing reliance on chemical inputs and enhancing food security in the face of climate change. Across these segments, epigenetics supports innovation, precision, and sustainability, highlighting its broad applications and transformative potential.

What Are the Key Drivers Fueling Growth in the Epigenetics Market?

The growth in the epigenetics market is driven by several key factors, including rising prevalence of chronic and complex diseases, increasing demand for personalized medicine, and advancements in research technologies. The rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurodegenerative disorders, is a primary driver as these conditions are often influenced by epigenetic modifications. Epigenetics provides insights into disease mechanisms and offers therapeutic targets for conditions with limited treatment options, driving investment in epigenetic research and drug development.

The increasing demand for personalized medicine is another significant driver, as healthcare shifts toward tailored approaches that address individual variations in disease susceptibility and response to treatment. Epigenetic biomarkers enable stratification of patient populations and guide the development of targeted therapies, particularly in oncology and rare genetic disorders. The ability to use epigenetic data to predict treatment efficacy and monitor disease progression enhances the precision and effectiveness of medical interventions, aligning with the broader trend of precision healthcare.

Advancements in research technologies, including next-generation sequencing, single-cell analysis, and bioinformatics, are also propelling the market. These technologies provide the tools needed to explore the complex and dynamic nature of epigenetic regulation, enabling breakthroughs in understanding and application. The integration of AI and machine learning further accelerates discoveries by identifying patterns and correlations in large epigenetic datasets. These technological advancements lower the cost and complexity of epigenetics research, making it more accessible to academic, clinical, and commercial entities.

Together, these drivers—disease prevalence, personalized medicine demand, and technological advancements—are fueling growth in the epigenetics market. As industries continue to leverage epigenetic insights to address unmet medical needs and innovate across sectors, epigenetics is poised to play a central role in shaping the future of healthcare, agriculture, and beyond.

SCOPE OF STUDY:

The report analyzes the Epigenetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes, Epigenetics Instruments & Consumables); Technology (DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology, Chromatin Structures Technology); Application (Oncology Application, Non-Oncology Application)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 95 Featured) -

  • Abnova Corporation
  • Active Motif, Inc.
  • biomodal Ltd.
  • Bio-Rad Laboratories, Inc.
  • BPS Bioscience, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • EpiCypher, Inc.
  • Epigentek Group Inc.
  • Fios Genomics Ltd.
  • Genomescan
  • Illumina, Inc.
  • Merck Millipore
  • New England Biolabs, Inc.
  • Novogene Co. Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • Qiagen, Inc.
  • Revvity, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Human Quest for Supremacy Over Diseases Sets the Tone for Growth of Epigenetics as a Transformative Force in Healthcare
    • EXHIBIT 1: Medical Research is Sacrosanct & So is Epigenetics' Role as a Catalyst for Health Transformation: Global Pharmaceutical Research and Development Spending (In US$ Billion) for Years 2025, 2027, 2029, and 2031
    • Economic Frontiers: Trends, Trials & Transformations
    • EXHIBIT 2: In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 3: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • EXHIBIT 4: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • Competition
    • EXHIBIT 5: Epigenetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 95 Players Worldwide in 2024 (E)
    • What is Epigenetics? A Technical Rumination
    • Influencer/Product/Technology Insights
    • Recent Market Activity
    • Innovations
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Diseases Sets the Stage for Growth of Epigenetics
    • EXHIBIT 6: As Disease Burden Rises So Does the Value of Epigenetics in Understanding Diseases & Developing Cutting Edge Therapies: Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
    • Growing Focus on Understanding Inflammatory Musculoskeletal Diseases Brings Epigenetics Into the Spotlight
    • EXHIBIT 7: Growing Burden of Musculoskeletal Disorders (MSDs) Pins Hope on Epigenetics for Solutions: Global Prevalence of MSDs (In Million) for Years 2024, 2030, 2040 and 2050
    • Exponential Rise in Cancer Pins Hope on Epigenetic Therapies
    • EXHIBIT 8: Rising Cancer Burden Exerts Pressure on Epigenetics to Move Swiftly from Laboratory Studies and Clinical Trials to Precision Medicine: Global Incidence of Cancer (In Million) for Years 2020, 2030 and 2040
    • The Shift Towards Personalized Medicine Expands The Role Of Epigenetics
    • EXHIBIT 9: As Personalized Medicine Gains Momentum, New Doors of Opportunities Open for Epigenome-Based Personalized Medicine: Global Market for Personalized Medicine (In US$ Billion) for Years 2025, 2027, 2029, 2031 and 2033
    • A New Era for Epigenetic Studies Open with the Entry of Artificial Intelligence
    • EXHIBIT 10: The Potential for Applying Artificial Intelligence to Epigenetics is Just Emerging Supported by Growing AI Spending: Global Spending on AI in Healthcare (In US$ Billion) for Years 2025, 2027, 2029, 2031, and 2033
    • Advancements in Epigenome Editing Drives Growth in the Market
    • Focus on Crop Improvement Amid Climate Change Drives Up the Value of Epigenetics in Agriculture
    • EXHIBIT 11: Inverse Relationship Between Rising Temperatures Due to Emissions Induced Climate Change & Crop Productivity Drives Interest in Epigenetics for Plant Breeding: Global CO2 Emissions (In Billion Metric Tons) for Years 1960, 1970, 1980, 1990, 2000, 2010, 2020, 2021, 2022, 2023 and 2024
    • Ethical Issues Continue to Surround the Field of Epigenetics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Epigenetics Market Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 4: World 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2019, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 7: World 11-Year Perspective for Epigenetics Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 10: World 11-Year Perspective for Epigenetics Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 13: World 11-Year Perspective for Epigenetics Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 16: World 11-Year Perspective for Epigenetics Instruments & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 19: World 11-Year Perspective for DNA Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 22: World 11-Year Perspective for Histone Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 25: World 11-Year Perspective for Histone Acetylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 28: World 11-Year Perspective for Large Non-Coding RNA Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 31: World 11-Year Perspective for MicroRNA Modification Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 34: World 11-Year Perspective for Chromatin Structures Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 37: World 11-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 40: World 11-Year Perspective for Non-Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 41: USA Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 43: USA 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 46: USA 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 49: USA 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 52: Canada 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 55: Canada 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 58: Canada 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • JAPAN
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 61: Japan 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 64: Japan 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 67: Japan 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CHINA
    • TABLE 68: China Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 70: China 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 73: China 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 76: China 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • EUROPE
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 79: Europe 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2019, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 82: Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 85: Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 88: Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • FRANCE
    • TABLE 89: France Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 91: France 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 94: France 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 97: France 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • GERMANY
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 100: Germany 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 103: Germany 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 106: Germany 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 109: Italy 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 112: Italy 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 115: Italy 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 116: UK Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 118: UK 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 121: UK 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 124: UK 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ASIA-PACIFIC
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 145: Rest of World 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 148: Rest of World 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 151: Rest of World 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030

IV. COMPETITION